CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Reconciliation of net income to cash used by operating activities:
Net income	$ 19,069	$ 5,416
Add (deduct):
Depreciation and amortization	16,855	15,322
Adjustments for bad debt provisions	1,846	922
Net realized and unrealized gains	(2,902)	(3,053)
Amortization of net discount on debt securities investments	(405)	(527)
Payments for title losses in excess of provisions	(6,023)	(1,337)
Increase in receivables – net	(25,086)	(15,226)
Increase in other assets – net	(9,710)	(16,619)
Decrease in accounts payable and other liabilities – net	(4,025)	(18,737)
Change in net deferred income taxes	1,230	(24)
Net income from equity method investments	(249)	(269)
Dividends received from equity method investments	559	585
Stock-based compensation expense	4,171	3,488
Other – net	180	132
Cash used by operating activities	(4,490)	(29,927)
Investing activities:
Proceeds from sales of investments in securities	1,006	16,009
Proceeds from matured investments in debt securities	13,855	11,864
Purchases of investments in securities	(18,805)	(22,377)
Net sales (purchases) of short-term investments	135	(4,275)
Purchases of property and equipment and other long-lived assets	(16,442)	(12,314)
Proceeds from sale of property and equipment and other assets	53	1,537
Cash paid for acquisition of businesses and related assets	(1,905)	(7,424)
Increase in notes receivable	0	(2,500)
Purchases of cost-basis and other investments	(71)	(909)
Other – net	319	382
Cash used by investing activities	(21,855)	(20,007)
Financing activities:
Proceeds from notes payable	2,564	995
Payments on notes payable	(2,503)	(1,115)
Distributions to noncontrolling interests	(3,948)	(3,850)
Contributions from noncontrolling interests	112	0
Repurchases of Common Stock	(5,233)	(3,365)
Proceeds from stock option and employee stock purchase plan exercises	2,803	2,897
Cash dividends paid	(16,341)	(13,942)
Payment of contingent consideration related to acquisitions	(316)	(265)
Cash used by financing activities	(22,862)	(18,645)
Effects of changes in foreign currency exchange rates	(1,333)	791
Change in cash and cash equivalents	(50,540)	(67,788)
Cash and cash equivalents at beginning of period	321,775	216,298
Cash and cash equivalents at end of period	$ 271,235	$ 148,510